First-of-a-kind drug approvals continued rise in 2015
Approvals for first-of-a-kind drugs climbed last year, pushing the annual tally of new U.S. drugs to its highest level in 19 years.
Jan 4, 2016
0
5
Approvals for first-of-a-kind drugs climbed last year, pushing the annual tally of new U.S. drugs to its highest level in 19 years.
Jan 4, 2016
0
5
A new immunotherapy drug has been approved for NHS patients in England whose melanoma has stopped responding to previous treatments.
Sep 9, 2015
0
10
Treatment options for chronic hepatitis C, a serious and life-threatening infection, have improved substantially and several new regimens with shorter durations and improved efficacy and safety profiles are now available.
Jun 2, 2015
0
11
Many potentially efficient drugs have been created to treat neurological disorders, but they cannot be used in practice. Typically, for a condition such as epilepsy, it is essential to act at exactly the right time and place ...
Apr 16, 2015
0
26
A biotech drug from Roche moved one step closer Thursday to becoming the first medicine approved to treat breast cancer before surgery.
Sep 12, 2013
0
0
Generally, FDA-approved clinical trials progress through three phases: the first shows safety, the second starts to explore effects and the third seeks to prove a drug's superiority over existing treatments. But when a drug's ...
Aug 8, 2013
0
0
Colorectal cancer is the second leading cause of cancer-related deaths in the United States. Once colorectal cancer has spread to other parts of the body, only 11 percent of patients will survive five years from the date ...
Apr 7, 2013
0
0
Ocular Systems, Inc. (OSI), Wake Forest Baptist Medical Center and the North Carolina Eye Bank have formed a new company based on a promising new technology aimed at engineering replacement corneas in the lab for transplantation.
Jan 8, 2013
0
0
Leading scientists have selected the first drugs to be evaluated in a worldwide clinical study to determine whether they can prevent Alzheimer's disease.
Oct 10, 2012
0
0
Investigators at Northwestern University Feinberg School of Medicine have identified two promising therapies to treat patients with acute megakaryocytic leukemia (AMKL), a rare form of leukemia where the number of cases is ...
Sep 20, 2012
0
0